Scarica l'app Stockscreener
23.32
2.26%
-0.54
Dopo l'orario di chiusura:
23.32
Precedente Chiudi:
$23.86
Aprire:
$23.75
Volume 24 ore:
742.88K
Relative Volume:
1.05
Capitalizzazione di mercato:
$2.87B
Reddito:
$1.80B
Utile/perdita netta:
$15.62M
Rapporto P/E:
194.33
EPS:
0.12
Flusso di cassa netto:
$118.36M
1 W Prestazione:
+1.22%
1M Prestazione:
-2.06%
6M Prestazione:
+13.31%
1 anno Prestazione:
+6.73%
Intervallo 1D:
$23.24
$23.94
Intervallo di 1 settimana:
$22.59
$24.00
Portata 52W:
$18.77
$26.51
Privia Health Group Inc Stock (PRVA) Company Profile
Nome
Privia Health Group Inc
Settore
Industria
Telefono
571-366-8850
Indirizzo
950 N. GLEBE RD., SUITE 700, ARLINGTON
Confronta PRVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
23.32 | 2.93B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
222.21 | 35.99B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.33 | 12.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
41.26 | 7.73B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
85.37 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.20 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-01-10 | Iniziato | Needham | Buy |
| 2024-12-16 | Iniziato | Macquarie | Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-22 | Iniziato | Citigroup | Buy |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Ripresa | Jefferies | Buy |
| 2024-02-22 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-03-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-02-03 | Iniziato | Goldman | Buy |
| 2022-12-09 | Iniziato | Stifel | Buy |
| 2022-12-08 | Iniziato | UBS | Buy |
| 2022-09-07 | Ripresa | Truist | Buy |
| 2022-05-03 | Iniziato | BofA Securities | Buy |
| 2022-04-28 | Iniziato | BTIG Research | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2022-02-22 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2022-01-03 | Iniziato | Jefferies | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-05-24 | Iniziato | Canaccord Genuity | Buy |
| 2021-05-24 | Iniziato | Credit Suisse | Outperform |
| 2021-05-24 | Iniziato | JP Morgan | Overweight |
| 2021-05-24 | Iniziato | Piper Sandler | Overweight |
| 2021-05-24 | Iniziato | Truist | Buy |
| 2021-05-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Privia Health Group Inc Borsa (PRVA) Ultime notizie
Aug Chart Watch: Is Privia Health Group Inc stock overvalued or fairly pricedJuly 2025 Decliners & AI Driven Price Forecasts - baoquankhu1.vn
Privia Health Group Inc (PRVA) Trading 4.29% Higher on Jan 15 - GuruFocus
Buyback Watch: Does Privia Health Group Inc have strong EBITDA marginsJuly 2025 Reactions & Scalable Portfolio Growth Methods - baoquankhu1.vn
Earnings Miss: Why Privia Health Group Inc stock could be next big winner2025 Volume Leaders & High Conviction Trade Alerts - Bộ Nội Vụ
Technical Reactions to PRVA Trends in Macro Strategies - Stock Traders Daily
Robeco Institutional Asset Management B.V. Acquires Shares of 51,756 Privia Health Group, Inc. $PRVA - MarketBeat
Privia Health Group (NASDAQ:PRVA) Upgraded at Royal Bank Of Canada - Defense World
Privia Health Group (NASDAQ:PRVA) Raised to Moderate Buy at Royal Bank Of Canada - MarketBeat
Privia Health Group (NASDAQ:PRVA) Now Covered by Royal Bank Of Canada - Defense World
RBC Capital Reinstates Coverage of PRVA with "Outperform" Rating - GuruFocus
Royal Bank Of Canada Initiates Coverage on Privia Health Group (NASDAQ:PRVA) - MarketBeat
Will Privia Health Group Inc. stock recover faster than peers2025 Trading Recap & Consistent Profit Focused Trading Strategies - ulpravda.ru
Privia Health stock rating initiated at Outperform by RBC Capital - Investing.com South Africa
Privia Health stock rating initiated at Outperform by RBC Capital By Investing.com - Investing.com Nigeria
Is Privia Health Group Inc. stock a dividend growth opportunityEarnings Beat & Weekly Watchlist for Hot Stocks - ulpravda.ru
Can Privia Health Group Inc. stock attract ESG capital inflowsJuly 2025 Trends & Weekly Top Performers Watchlists - Улправда
Market Cool On Privia Health Group, Inc.'s (NASDAQ:PRVA) Revenues - 富途牛牛
Citizens reiterates Market Outperform rating on Privia Health stock By Investing.com - Investing.com South Africa
Citizens reiterates Market Outperform rating on Privia Health stock - Investing.com
Evolent Health (EVH) sells ACO unit, strengthens balance sheet - MSN
Privia Health Group Inc Stock Analysis and ForecastLow Beta Stocks & Free Superior Trading Gains - earlytimes.in
3 Stocks That May Be Trading Below Their Estimated Value - Sahm
Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock Has Shown A Decent Performance: Have Financials A Role To Play? - 富途牛牛
Privia Health Group, Inc. $PRVA Shares Sold by Corient Private Wealth LLC - Defense World
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health - The Globe and Mail
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Privia Health Group Adjusts Valuation Amid Evolving Market Dynamics in Insurance Sector - Markets Mojo
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run - The Globe and Mail
Evolent Health (EVH) Sells ACO Unit, Strengthens Balance Sheet - Finviz
Riverbridge Partners LLC Has $115.38 Million Position in Privia Health Group, Inc. $PRVA - MarketBeat
Signal Recap: Why hedge funds are buying Privia Health Group Inc. stockJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - Улправда
Why hedge funds are buying Privia Health Group Inc. stock2025 EndofYear Setup & Risk Managed Investment Entry Signals - Улправда
Can Privia Health Group Inc. stock surprise with earnings upsideJuly 2025 Market Mood & Community Verified Watchlist Alerts - DonanımHaber
Q3 2025 Healthcare Technology Earnings Review: Revenue Beats & Stock PerformanceNews and Statistics - IndexBox
Privia Health Group (NASDAQ:PRVA) CFO Sells $597,891.61 in Stock - Defense World
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Novan (NOVN) - The Globe and Mail
Privia Health finalizes acquisition of ACO business - MSN
Privia Health Group (NASDAQ:PRVA) Director Matthew Shawn Morris Sells 13,647 Shares - MarketBeat
[Form 4] Privia Health Group, Inc. Insider Trading Activity - Stock Titan
Here's Why We Think Privia Health Group (NASDAQ:PRVA) Is Well Worth Watching - Yahoo Finance
Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - simplywall.st
1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down - Finviz
Bellevue Group AG Trims Stock Position in Privia Health Group, Inc. $PRVA - MarketBeat
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Exelixis (EXEL) and Natera (NTRA) - The Globe and Mail
3 Reasons to Sell PRVA and 1 Stock to Buy Instead - Yahoo Finance
Privia Health Group Inc Azioni (PRVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Privia Health Group Inc Azioni (PRVA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Morris Matthew Shawn | Director |
Dec 12 '25 |
Sale |
25.01 |
13,647 |
341,311 |
68,188 |
| Mountcastle David | EVP & Chief Financial Officer |
Dec 12 '25 |
Option Exercise |
2.00 |
23,887 |
47,774 |
196,796 |
| Mountcastle David | EVP & Chief Financial Officer |
Dec 12 '25 |
Sale |
25.03 |
23,887 |
597,892 |
172,909 |
3.21%
2.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):